AKT1 and VEGFA were selected as most of the compounds targeted these genes, and these genes are mainly linked to ovarian cancer-related pathways, including the estrogen signaling pathway, progesterone-mediated oocyte maturation, the prolactin signaling pathway, Rap1 and ErbB signaling pathways, colorectal cancer, growth hormone action, secretion, and synthesis, and endometrial cancer. This evidence concerns the gene GH1 and ovarian carcinoma.